HWAM
ABBV icon

Hennion & Walsh Asset Management’s AbbVie ABBV Stock Holding History

Hennion & Walsh Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6M Buy
23,832
+450
+2% +$96.8K 0.17% 146
2026
Q1 		$5.09M Sell
23,382
-2,623
-10% -$582K 0.17% 146
2025
Q4 		$5.94M Sell
26,005
-1,392
-5% -$317K 0.21% 109
2025
Q3 		$6.34M Buy
27,397
+688
+3% +$140K 0.23% 87
2025
Q2 		$4.96M Sell
26,709
-1,559
-6% -$290K 0.2% 116
2025
Q1 		$5.92M Sell
28,268
-4,538
-14% -$882K 0.26% 74
2024
Q4 		$5.83M Sell
32,806
-45
-0.1% -$8.27K 0.26% 79
2024
Q3 		$6.48M Buy
32,851
+4,688
+17% +$875K 0.3% 62
2024
Q2 		$4.83M Sell
28,163
-273
-1% -$45.2K 0.25% 91
2024
Q1 		$5.18M Sell
28,436
-3,848
-12% -$663K 0.28% 76
2023
Q4 		$5M Sell
32,284
-4,849
-13% -$707K 0.29% 73
2023
Q3 		$5.54M Sell
37,133
-6,236
-14% -$915K 0.35% 50
2023
Q2 		$5.84M Buy
43,369
+3,527
+9% +$517K 0.35% 61
2023
Q1 		$6.35M Buy
39,842
+62
+0.2% +$9.48K 0.39% 58
2022
Q4 		$6.43M Buy
39,780
+6,151
+18% +$943K 0.4% 58
2022
Q3 		$4.51M Buy
33,629
+16
+0% +$2.3K 0.3% 80
2022
Q2 		$5.15M Buy
33,613
+7,099
+27% +$1.08M 0.32% 75
2022
Q1 		$4.3M Sell
26,514
-838
-3% -$122K 0.23% 118
2021
Q4 		$3.7M Sell
27,352
-1,643
-6% -$194K 0.18% 151
2021
Q3 		$3.13M Buy
28,995
+257
+0.9% +$29.4K 0.16% 182
2021
Q2 		$3.24M Buy
28,738
+1,720
+6% +$194K 0.17% 171
2021
Q1 		$2.92M Buy
+27,018
New +$2.89M 0.18% 166

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hennion & Walsh Asset Management's ABBV Position: Q2 2026 in Review

Hennion & Walsh Asset Management increased its AbbVie (ABBV) stake by 1.9% in Q2 2026, buying an estimated $96.8K and bringing the position to 23,832 shares worth $6M. The position accounts for 0.17% of the portfolio, ranked #146.

Hennion & Walsh Asset Management first reported a position in ABBV in Q1 2021 and has held it in 22 quarters since. The position peaked at $6.48M in Q3 2024. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Hennion & Walsh Asset Management held 23,832 shares of AbbVie worth $6M as of Q2 2026.
  • Hennion & Walsh Asset Management bought 450 AbbVie shares in Q2 2026, an estimated $96.8K.
  • AbbVie made up 0.17% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #146 holding.
  • Hennion & Walsh Asset Management first reported a position in AbbVie in Q1 2021 and has held it in 22 quarters since.
  • Hennion & Walsh Asset Management's AbbVie position peaked at $6.48M in Q3 2024.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.